Doris Duke Foundation Director for Medical Research Sindy Escobar Alvarez, Ph.D., sat down with three of the country’s top sickle cell disease researchers to yield insights from the strides being made through their innovative research, examine the field’s most substantial challenges and discuss the most potent opportunities ahead. Hear from Daniel Bauer, M.D., Ph.D, hematologist at Boston Children’s Hospital and associate professor at Harvard Medical School; Donald B. Kohn, M.D., of University of California, Los Angeles; and Punam Malik, M.D., Marjorie Johnson Chair of Gene and Cell Therapy at Cincinnati Children’s Hospital, as they share what they have learned through their work in this disease area, why this is an opportune moment to accelerate curative therapies for sickle cell anemia and what the field needs to meet the moment.
Негізгі бет Breakthroughs in Sickle Cell Disease Research: Promising Approaches in Gene Modification
Пікірлер: 5